View Older Stories View More Recent Stories
-
Sarepta (SRPT) Trades Higher on Eteplirsen Phase II Update, Analyst Comments
-
Lazard Capital Downgrades Kayak Software (KYAK) to Neutral
-
Lazard Capital Downgrades Progenics Pharmaceuticals (PGNX) to Neutral
-
Lazard Capital Downgrades STEC, Inc. (STEC) to Neutral
-
Lazard Capital Upgrades Demandware (DWRE) to Buy
-
Lazard Capital Starts Kythera Biopharmaceuticals (KYTH) at Buy
-
MSCI (MSCI) Unit to Acquire IPD Group in $125M Deal
-
Notable Analyst Rating Changes 10/26: (CSTR) (CME) (PG) Upgraded; (CLF) (CAT) (CTCT) Downgraded
-
Lazard Capital Downgrades Starwood Hotels & Resorts (HOT) to Neutral
-
Lazard Capital Upgrades Varian Medical (VAR) to Buy
-
Lazard Capital Downgrades Constant Contact (CTCT) to Neutral
-
Lazard (LAZ) Tops Q3 EPS by 4c
-
Lazard Capital Downgrades TriQuint Semiconductor (TQNT) to Neutral
-
Trading Radar for 10/25: Apple (AAPL), Sprint (S), Amazon (AMZN), Clearwire (CLWR), Procter & Gamble (PG), Dunkin' Brands (DNKN), Expedia (EXPE) Report
-
Lazard Class A (LAZ) Declares $0.20 Quarterly Dividend; 2.8% Yield
-
Lazard Capital Starts Bazaarvoice (BV) at Neutral
-
Notable Analyst Rating Changes 10/22: (BBT) (BEAM) (AMGN) Upgraded; (SNDK) (DDR) (TLM) Downgraded
-
Lazard Capital Starts Qualys (QLYS) at Buy
-
Notable Analyst Rating Changes 10/19: (ISRG) (ABT) (NOK) Upgraded; (NVDA) (JNS) (GOOG) Downgraded
-
A123 Systems (AONE) Receives Bankruptcy Court Approval to Use $15.5M of DIP Financing
-
Lazard Capital Starts Sunshine Heart (SSH) at Buy
-
Lazard Capital Downgrades Marvell (MRVL) to Neutral
-
ImmunoCellular (IMUC) Plans Public Offering
-
Notable Analyst Rating Changes 10/17: (FTNT) (C) (ORI) Upgraded; (MUR) (IBM) (CSCO) Downgraded
-
Lazard Capital Starts American Axle (AXL) at Neutral
-
Overseas Shipholding (OSG) Falls on Liquidity Fears
-
Stocks Crossing 50-Day SMA 10/15: (RF) (SNDK) (CSCO) Above; (EBAY) (DCTH) (HRS) Below
-
Lazard Capital Downgrades Harris Corp. (HRS) to Sell
-
IPO for "Double Chin" Solver KYTHERA Biopharmaceuticals (KYTH) iPO Opens 16% Higher
-
Lazard Capital Downgrades SAIC, Inc. (SAI) to Neutral
-
Lazard Capital Downgrades Booz Allen Hamilton (BAH) to Sell
-
Keefe, Bruyette & Woods Downgrades Lazard (LAZ) to Market Perform
-
UBS Starts Lazard (LAZ) at Sell
-
Principal Financial (PFG) to Acquire Cuprum in $1.51B Deal
-
Notable Analyst Rating Changes 10/08: (PCS) (NFLX) (GILD) Upgraded; (FB) (DIS) (KEY) Downgraded
-
Lazard Capital Upgrades Gilead Sciences (GILD) to Buy
-
Notable Analyst Rating Changes 10/05: (FIS) (INFA) (DLTR) Upgraded; (HPQ) (ADTN) (FSLR) Downgraded
-
Lazard Capital Downgrades Mercury Computer (MRCY) to Neutral After Warning
-
Lazard Capital Starts Skyworks Solutions (SWKS) at Buy
-
Lazard Capital Starts RF Micro Devices (RFMD) at Neutral
-
Lazard Capital Downgrades Marriott International (MAR) to Neutral
-
Lazard Capital Starts TriQuint Semiconductor (TQNT) at Buy
-
Lazard Capital Starts ICF International (ICFI) at Neutral
-
Lazard Capital Starts NCI, Inc. (NCIT) at Neutral
-
JMP Securities Downgrades Lazard (LAZ) to Market Perform
-
Notable Analyst Rating Changes 10/03: (CSX) (AXL) (SMTC) Upgraded; (AMRN) (POT) (TXN) Downgraded
-
Notable Mergers and Acquisitions of the Day 10/03: (PCS) (OCN) (CG) (SVU)
-
Pre-Open Movers 10/03: (SRPT) (ITMN) (BBY) Higher; (XRTX) (ATRS) (SPN) Lower (more...)
-
MetroPCS (PCS) to Merge with Deutsche Telekom's T-Mobile USA Unit
-
Sarepta Therapeutic (SRPT) Could Be Worth $83-$139/Sh - Analyst

